Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06274736

Safety and Performance of Motiva® Sizers

Post-marketing Cohort Study to Confirm the Safety and Performance of Motiva® Sizers in Breast Augmentation and Reconstruction Procedures

Status
Recruiting
Phase
Study type
Observational
Enrollment
330 (estimated)
Sponsor
Establishment Labs · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The Motiva® Sizer clinical study is a four-year, multicenter, post-marketing, and cohort study, designed to confirm the safety and performance of Motiva® Sizer in breast augmentation or reconstruction procedures. The research will include 330 women, divided into two groups of 165 participants each (150 breast augmentation participants and 15 reconstruction participants). The Motiva® Sizer exposed group will consist of women who will undergo breast augmentation or reconstruction surgery with the use of Motiva® Sizer during the procedure, and a non-exposed group will consist of women who will undergo breast augmentation or reconstruction surgery without the use of Motiva® Sizer. This study will be conducted in Costa Rica. The main goal is to evaluate the safety and the performance of the Motiva® Sizer. To this end, the results of both groups will be compared in terms of surgical complications, surgeon's, and participant's satisfaction level as well as reoperation rates. After the augmentation or reconstruction surgery, participants will be scheduled for the following follow-up visits, (1) between 3 and 7 postoperative days, (2) between 3 and 6 postoperative weeks, (3) at 3 and (4) 6 postoperative months, and (5, 6 and 7) annually thereafter for a period of three consecutive years. In case any participant has an adverse event due to the procedure, and if required by the physician, an additional visit will be made to assess her, and this information as well as that of the scheduled visits should be recorded in the electronic data collection notebook.

Conditions

Interventions

TypeNameDescription
DEVICEMotiva SizerNo intervention will be made,

Timeline

Start date
2023-04-10
Primary completion
2027-04-10
Completion
2027-07-10
First posted
2024-02-23
Last updated
2024-02-23

Locations

1 site across 1 country: Costa Rica

Regulatory

Source: ClinicalTrials.gov record NCT06274736. Inclusion in this directory is not an endorsement.